Population mobility and the changing epidemics of HIV-2 in Portugal-Reference-Cited by-同舟云学术

Population mobility and the changing epidemics of HIV-2 in Portugal

Published:2011-12-04 Issue: Volume: Page:n/a-n/a
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Carvalho AC,Valadas E¹,França L²,Carvalho C³,Aleixo MJ⁴,Mendez J⁵,Marques R⁶,Sarmento A⁶,Doroana M¹,Antunes F¹,Branco T³,Águas M⁴,Sarmento e Castro R⁵,Lazarus JV,Barros H

Affiliation:

1. Hospital Santa Maria; Lisbon; Portugal

2. Hospital St António Capuchos; Lisbon; Portugal

3. Hospital Fernando da Fonseca; Lisbon; Portugal

4. Hospital Garcia da Orta; Lisbon; Portugal

5. Hospital Joaquim Urbano; Porto; Portugal

6. Hospital São João; Porto; Portugal

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1293.2011.00963.x/fullpdf

Reference26 articles.

1. AIDS as a zoonosis: scientific and public health implications;Hahn;Science,2000

2. Vertical transmission of HIV-2;Cavaco-Silva;Lancet,1997

3. Slower heterosexual spread of HIV-2 than HIV-1;Kanki;Lancet,1994

4. HIV-2: the forgotten AIDS virus;Silva;Trends Microbiol,2008

5. Lessons from the second AIDS virus, HIV-2;Marlink;AIDS,1996

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are Confirmatory Assays Reliable for HIV-1/HIV-2 Infection Differentiation? A Multicenter Study;Journal of Clinical Microbiology;2023-07-17

2. Human Immunodeficiency Virus Type 2: The Neglected Threat;Pathogens;2021-10-25

3. The Epidemiological Analysis of HIV/AIDS Patients: Sexually Transmitted Diseases Department vs. other Departments in A General Hospital of Shanghai, China;Current HIV Research;2021-09-08

4. Human Immunodeficiency Virus (HIV) 2 Superinfection in a Patient Receiving Antiretroviral Therapy With Longstanding HIV-1 Viral Load Suppression;Open Forum Infectious Diseases;2019-02-12

5. In vitro evaluation of novel reverse transcriptase inhibitors TAF (tenofovir alafenamide) and OBP-601 (2,3-didehydro-3-deoxy-4-ethynylthymidine) against multi-drug resistant primary isolates of HIV-2;Antiviral Research;2019-01